Source: Markets Insider

Affera: Affera, Inc. Announces Successful First-In-Human Use Of SpherePVI Circumferential Pulmonary Vein Isolation Device Using Pulsed Field Energy

WATERTOWN, Mass., July 27, 2021 /PRNewswire/ -- Affera, Inc., a private medical device company focused on innovative cardiac arrhythmia treatment ...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Doron Harlev's photo - Founder & CEO of Affera

Founder & CEO

Doron Harlev

CEO Approval Rating

90/100

Read more